An Inverse Relationship Between Age of Type 2 Diabetes Onset and Complication Risk and Mortality: The Impact of Youth-Onset Type 2 Diabetes
Autor: | Franziska Limacher-Gisler, Abdulghani Al-Saeed, Ted Wu, Dennis K. Yue, Maria I. Constantino, Jencia Wong, Connie Luo, Stephen M. Twigg, Mario D'Souza, Lynda Molyneaux |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adult
Male Pediatrics medicine.medical_specialty Adolescent Endocrinology Diabetes and Metabolism Population 030209 endocrinology & metabolism Type 2 diabetes National Death Index Diabetes Complications Young Adult 03 medical and health sciences 0302 clinical medicine Risk Factors Prevalence Internal Medicine Humans Medicine 030212 general & internal medicine Age of Onset Young adult education Survival analysis Aged Advanced and Specialized Nursing education.field_of_study business.industry Australia Middle Aged medicine.disease Survival Analysis Middle age Surgery Diabetes Mellitus Type 2 Cohort Female Age of onset business |
Zdroj: | Diabetes Care. 39:823-829 |
ISSN: | 1935-5548 0149-5992 |
DOI: | 10.2337/dc15-0991 |
Popis: | OBJECTIVE This study compared the prevalence of complications in 354 patients with T2DM diagnosed between 15 and 30 years of age (T2DM15–30) with that in a duration-matched cohort of 1,062 patients diagnosed between 40 and 50 years (T2DM40–50). It also examined standardized mortality ratios (SMRs) according to diabetes age of onset in 15,238 patients covering a wider age-of-onset range. RESEARCH DESIGN AND METHODS Complication status was assessed according to a standard protocol and extracted from our electronic database. Survival status was ascertained by data linkage with the Australian National Death Index. SMRs were calculated in comparison with the background Australian population and analyzed according to age of onset. RESULTS After matching for duration, despite their younger age, T2DM15–30 had more severe albuminuria (P = 0.004) and neuropathy scores (P = 0.003). T2DM15–30 were as commonly affected by metabolic syndrome factors as T2DM40–50 but less frequently treated for hypertension and dyslipidemia (P < 0.0001). An inverse relationship between age of diabetes onset and SMR was seen, which was the highest for T2DM15–30 (3.4 [95% CI 2.7–4.2]). SMR plots adjusting for duration show that for those with T2DM15–30, SMR is the highest at any chronological age, with a peak SMR of more than 6 in early midlife. In contrast, mortality for older-onset groups approximates that of the background population. CONCLUSIONS The negative effect of diabetes on morbidity and mortality is greatest for those diagnosed at a young age compared with T2DM of usual onset. These results highlight the growing imperative to direct attention toward young-onset T2DM and for effective interventions to be applied before middle age. |
Databáze: | OpenAIRE |
Externí odkaz: |